Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proposed BioRepository platform solution for the ALS research community.
Sherman A, Bowser R, Grasso D, Power B, Milligan C, Jaffa M, Cudkowicz M. Sherman A, et al. Among authors: cudkowicz m. Amyotroph Lateral Scler. 2011 Jan;12(1):11-6. doi: 10.3109/17482968.2010.539233. Epub 2010 Dec 6. Amyotroph Lateral Scler. 2011. PMID: 21128868
Maximum voluntary isometric contraction (MVIC).
Cudkowicz M, Zhang H, Qureshi M, Schoenfeld D. Cudkowicz M, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:84-5. doi: 10.1080/17434470410019744. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512881 No abstract available.
North East ALS Study Group.
Cudkowicz M, Shefner J. Cudkowicz M, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:125-7. doi: 10.1080/17434470410019726. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512893 No abstract available.
Functional outcome measures as clinical trial endpoints in ALS.
Traynor BJ, Zhang H, Shefner JM, Schoenfeld D, Cudkowicz ME; NEALS Consortium. Traynor BJ, et al. Among authors: cudkowicz me. Neurology. 2004 Nov 23;63(10):1933-5. doi: 10.1212/01.wnl.0000144345.49510.4e. Neurology. 2004. PMID: 15557515 Clinical Trial.
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.
Ferrante KL, Shefner J, Zhang H, Betensky R, O'Brien M, Yu H, Fantasia M, Taft J, Beal MF, Traynor B, Newhall K, Donofrio P, Caress J, Ashburn C, Freiberg B, O'Neill C, Paladenech C, Walker T, Pestronk A, Abrams B, Florence J, Renna R, Schierbecker J, Malkus B, Cudkowicz M. Ferrante KL, et al. Among authors: cudkowicz m. Neurology. 2005 Dec 13;65(11):1834-6. doi: 10.1212/01.wnl.0000187070.35365.d7. Neurology. 2005. PMID: 16344537 Clinical Trial.
Biomarkers for amyotrophic lateral sclerosis.
Bowser R, Cudkowicz M, Kaddurah-Daouk R. Bowser R, et al. Among authors: cudkowicz m. Expert Rev Mol Diagn. 2006 May;6(3):387-98. doi: 10.1586/14737159.6.3.387. Expert Rev Mol Diagn. 2006. PMID: 16706741 Review.
Increased incidence of deep venous thrombosis in ALS.
Qureshi MM, Cudkowicz ME, Zhang H, Raynor E. Qureshi MM, et al. Among authors: cudkowicz me. Neurology. 2007 Jan 2;68(1):76-7. doi: 10.1212/01.wnl.0000250444.30622.ee. Neurology. 2007. PMID: 17200499 No abstract available.
Design of phase II ALS clinical trials.
Schoenfeld DA, Cudkowicz M. Schoenfeld DA, et al. Among authors: cudkowicz m. Amyotroph Lateral Scler. 2008;9(1):16-23. doi: 10.1080/17482960701875896. Amyotroph Lateral Scler. 2008. PMID: 18273715
316 results